1. Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes. Issue 3 (16th October 2021) Authors: Bressler, Neil M; Veith, Miroslav; Hamouz, Jan; Ernest, Jan; Zalewski, Dominik; Studnička, Jan; Vajas, Attila; Papp, András; Vogt, Gabor; Luu, James; Matuskova, Veronika; Yoon, Young Hee; Pregun, Tamás; Kim, Taehyung; Shin, Donghoon; Oh, Inkyung; Jeong, Hansol; Kim, Mercy Yeeun; Woo, Se Joon Journal: British journal of ophthalmology Issue: Volume 107:Issue 3(2023) Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗